Positive margins matter regardless of subsequent resection findings.


Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
05 2022
Historique:
received: 27 01 2022
revised: 22 03 2022
accepted: 30 03 2022
pubmed: 19 4 2022
medline: 4 5 2022
entrez: 18 4 2022
Statut: ppublish

Résumé

In the resection of oral cavity squamous cell carcinoma (OCSCC), an intraoperative positive surgical margin (SM) communicated to the head and neck surgeon necessitates further resection of the area of identified involvement to achieve a final negative SM. The prognostic implication of initial positive SM when the final SM is negative is understudied. We retrospectively reviewed 249 patients with non-metastatic (stage I-IVB) OCSCC who underwent a resection from 2010 to 2019 to assess the prognostic impact of an initial positive SM. Chi-squared analysis was used to evaluate the association between an initial positive SM and clinicopathologic parameters. A Kaplan-Meier analysis was performed to estimate patient outcomes with Cox regression analysis used to determine absolute hazards. At a median follow-up of 28.4 months, the 2-year freedom from local recurrence (FFLR), disease-free survival (DFS), and overall survival (OS) rates were 82.1%, 63.5%, and 78.5%, respectively. Fifty patients (20.1%) had an initial positive SM which was revised to a negative SM on frozen and permanent sections by resecting further tissue while 12 patients (4.8%) had a final positive SM. An initial positive SM was independently associated with a worse FFLR (HR: 2.696, p = 0.004), DFS (HR: 1.57, p = 0.044), and OS (HR: 1.72, p = 0.029). An initial positive SM is independently associated with worse disease control and patient survival. A positive SM may be a surrogate for diffusely infiltrative disease as further malignancy identified on the re-resection specimen was associated with worse outcomes.

Identifiants

pubmed: 35436713
pii: S1368-8375(22)00139-7
doi: 10.1016/j.oraloncology.2022.105850
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105850

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Brendan Coutu (B)

Department of Radiation Oncology, University of Nebraska Medical Center, 986861 Nebraska Medical Center, Omaha, NE 68198-6861, United States.

Evan Ryan (E)

Department of Otolaryngology, University of Nebraska Medical Center, 981225 Nebraska Medical Center, Omaha Nebraska 68198-1225, United States.

Dallin Christensen (D)

Department of Otolaryngology, University of Nebraska Medical Center, 981225 Nebraska Medical Center, Omaha Nebraska 68198-1225, United States.

Elliot Lawrence (E)

Department of Radiation Oncology, University of Nebraska Medical Center, 986861 Nebraska Medical Center, Omaha, NE 68198-6861, United States.

Elizabeth Bradford Bell (EB)

Department of Otolaryngology, University of Nebraska Medical Center, 981225 Nebraska Medical Center, Omaha Nebraska 68198-1225, United States.

Weining Zhen (W)

Department of Radiation Oncology, University of Nebraska Medical Center, 986861 Nebraska Medical Center, Omaha, NE 68198-6861, United States.

Zafar Sayed (Z)

Department of Otolaryngology, University of Nebraska Medical Center, 981225 Nebraska Medical Center, Omaha Nebraska 68198-1225, United States. Electronic address: zafar.sayed@unmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH